Viking Therapeutics, Inc. (VKTX): SCHEDULE 13G/A filed Mar 27, 2026

Form type

SCHEDULE 13G/A

Filing date

Mar 27, 2026

Accession number

0000102909-26-002541

Filer

Viking Therapeutics, Inc. (CIK 1607678)